Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 3

1(25.0%)

4Total

N/A(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07311824Not ApplicableNot Yet Recruiting

Pain Management for In-Office Gynecologic Procedures Using a Risk-Stratification Pain Calculator

Role: lead

NCT05479006Not ApplicableRecruiting

Determine the Effect of Targeted High-definition Transcranial Direct Current Stimulation (tDCS) on Reducing Post-stroke Upper Limb Motor Impairments

Role: lead

NCT02766322Terminated

Alcohol and Bariatric Surgery

Role: collaborator

NCT06257771Recruiting

Alcohol After Bariatric Surgery 2

Role: collaborator

NCT03890107Completed

Clinical Evaluation of the OtoSight

Role: collaborator

NCT03540693Unknown

Fat Taste Sensory Study

Role: collaborator

NCT02334293Not ApplicableUnknown

Omegaven® as Parenteral Nutrition

Role: lead

NCT00591591Phase 3Completed

Brain Oxygenation and Hemodynamics During Sleep in Obstructive Sleep Apnea Sufferers

Role: collaborator

All 8 trials loaded